We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
Cap. Flow
+$33.3M
Cap. Flow %
18.49%
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.54M
2
CHRS icon
Coherus Oncology
CHRS
+$3.29M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$2.71M
4
EMBC icon
Embecta
EMBC
+$2.55M
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.33M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$4.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.81M
3
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$2.81M
4
INVA icon
Innoviva
INVA
+$2.07M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 59.9%
2 Real Estate 10.66%
3 Financials 4.01%
4 Technology 3.46%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWN
276
DELISTED
Southwestern Energy Company
SWN
– –
-15,712
Closed -$78.6K
TARO
277
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-32,500
Closed -$790K
SLGC
278
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-239,500
Closed -$611K
VRAY
279
DELISTED
ViewRay, Inc.
VRAY
– –
-65,000
Closed -$225K
AMYT
280
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
– –
-81,000
Closed -$1.18M
8 9 10 11
12

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.

  • AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
  • AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
  • AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
  • AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
  • AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.

Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.